Relationship between serum Dickkopf-1 and albuminuria in patients with type 2 diabetes

Ning-Ning Hou1, Cheng-Xia Kan1, Na Huang1

  • 1Department of Endocrinology, Affiliated Hospital of Weifang Medical University, Weifang 261031, Shandong Province, China.

World Journal of Diabetes
|February 1, 2021
PubMed
Abstract

Insights

Lower serum Dickkopf-1 levels are linked to albuminuria in type 2 diabetes patients. This finding suggests Dickkopf-1 may be a risk factor for diabetic kidney disease progression.

Area of Science:

  • Nephrology
  • Endocrinology
  • Molecular Biology

Background:

  • Diabetic kidney disease (DKD) is a serious complication of diabetes.
  • Wingless (Wnt) signaling pathway dysregulation contributes to renal fibrosis in DKD.
  • Dickkopf-1 (DKK1), a Wnt inhibitor, plays roles in fibrosis, metabolism, and inflammation, but its association with DKD is unclear.

Purpose of the Study:

  • To investigate the relationship between serum Dickkopf-1 levels and albuminuria in type 2 diabetes (T2D).

Main Methods:

  • A case-control study involving 73 T2D patients and 24 healthy controls.
  • T2D patients were categorized by urinary albumin/creatinine ratio (UACR) into normal, microalbuminuria, and macroalbuminuria groups.
  • Serum DKK1 levels were measured using ELISA; clinical and metabolic data were collected.

Main Results:

  • Serum DKK1 levels were not significantly different between healthy individuals and the normal albuminuria group.
  • DKK1 levels were significantly lower in microalbuminuria and macroalbuminuria groups compared to the normal albuminuria group.
  • Serum DKK1 levels were independently associated with UACR (OR=0.627, P=0.021) and correlated with hemoglobin A1c, eGFR, diabetes duration, systolic blood pressure, serum creatinine, and UACR.

Conclusions:

  • Serum DKK1 levels are negatively associated with UACR in T2D patients.
  • Lower serum DKK1 levels may indicate an increased risk of albuminuria and DKD progression.

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
79
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
188
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
73
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
339
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
355
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.5K